|
1
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cunningham D, Allum WH, Stenning SP,
Thompson JN, van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ,
Falk SJ, Iveson TJ, et al: Perioperative chemotherapy versus
surgery alone for resectable gastroesophageal cancer. N Engl J Med.
355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Macdonald JS, Smalley SR, Benedetti J,
Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA,
Gunderson LL, Jessup JM, et al: Chemoradiotherapy after surgery
compared with surgery alone for adenocarcinoma of the stomach or
gastroesophageal junction. N Engl J Med. 345:725–730. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jass JR, Sobin LH and Watanabe H: The
World Health Organization’s histologic classification of
gastrointestinal tumors. A commentary on the second edition.
Cancer. 66:2162–2167. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Henson DE, Dittus C, Younes M, Nguyen H
and Albores-Saavedra J: Differential trends in the intestinal and
diffuse types of gastric carcinoma in the United States, 1973–2000:
increase in the signet ring cell type. Arch Pathol Lab Med.
128:765–770. 2004.PubMed/NCBI
|
|
6
|
Taghavi S, Jayarajan SN, Davey A and
Willis AI: Prognostic significance of signet ring gastric cancer. J
Clin Oncol. 30:3493–3498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shah MA and Kelsen DP: Gastric cancer: a
primer on the epidemiology and biology of the disease and an
overview of the medical management of advanced disease. J Natl
Compr Cancer Netw. 8:437–447. 2010.
|
|
8
|
Gilbert CA and Ross AH: Cancer stem cells:
cell culture, markers, and targets for new therapies. J Cell
Biochem. 108:1031–1038. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Passegue E, Rafii S and Herlyn M: Cancer
stem cells are everywhere. Nat Med. 15:232009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Palyi-Krekk Z, Barok M, Isola J, Tammi M,
Szollosi J and Nagy P: Hyaluronan-induced masking of ErbB2 and
CD44-enhanced trastuzumab internalisation in trastuzumab resistant
breast cancer. Eur J Cancer. 43:2423–2433. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bjorklund CC, Baladandayuthapani V, Lin
HY, Jones RJ, Kuiatse I, Wang H, Yang J, Shah JJ, Thomas SK, Wang
M, et al: Evidence of a role for CD44 and cell adhesion in
mediating resistance to lenalidomide in multiple myeloma:
therapeutic implications. Leukemia. 28:373–383. 2014. View Article : Google Scholar
|
|
12
|
Takaishi S, Okumura T, Tu S, Wang SS,
Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen S, Hou JH, Feng XY, Zhang XS, Zhou
ZW, Yun JP, Chen YB and Cai MY: Clinicopathologic significance of
putative stem cell marker, CD44 and CD133, in human gastric
carcinoma. J Surg Oncol. 107:799–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
She JJ, Zhang PG, Wang X, Che XM and Wang
ZM: Side population cells isolated from KATO III human gastric
cancer cell line have cancer stem cell-like characteristics. World
J Gastroenterol. 18:4610–4617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xue Z, Yan H, Li J, Liang S, Cai X, Chen
X, Wu Q, Gao L, Wu K, Nie Y, et al: Identification of cancer stem
cells in vincristine preconditioned SGC7901 gastric cancer cell
line. J Cell Biochem. 113:302–312. 2012. View Article : Google Scholar
|
|
16
|
Yanagihara K, Seyama T, Tsumuraya M,
Kamada N and Yokoro K: Establishment and characterization of human
signet ring cell gastric carcinoma cell lines with amplification of
the c-myc oncogene. Cancer Res. 51:381–386. 1991.PubMed/NCBI
|
|
17
|
Murakami H, Nakanishi H, Tanaka H, Ito S,
Misawa K, Ito Y, Ikehara Y, Kondo E and Kodera Y: Establishment and
characterization of novel gastric signet-ring cell and non
signet-ring cell poorly differentiated adenocarcinoma cell lines
with low and high malignant potential. Gastric Cancer. 16:74–83.
2013. View Article : Google Scholar
|
|
18
|
Sekiguchi M, Sakakibara K and Fujii G:
Establishment of cultured cell lines derived from a human gastric
carcinoma. Jpn J Exp Med. 48:61–68. 1978.PubMed/NCBI
|
|
19
|
Kreider BQ, Messing A, Doan H, Kim SU,
Lisak RP and Pleasure DE: Enrichment of Schwann cell cultures from
neonatal rat sciatic nerve by differential adhesion. Brain Res.
207:433–444. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin CH, Fu ZM, Liu YL, Yang JL, Xu JF,
Chen QS and Chen HM: Investigation of SGC-7901 cell line
established from human gastric carcinoma cells. Chin Med J (Engl).
97:831–834. 1984.
|
|
21
|
Kreso A and Dick JE: Evolution of the
cancer stem cell model. Cell Stem Cell. 14:275–291. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ithimakin S, Day KC, Malik F, Zen Q,
Dawsey SJ, Bersano-Begey TF, Quraishi AA, Ignatoski KW, Daignault
S, Davis A, et al: HER2 drives luminal breast cancer stem cells in
the absence of HER2 amplification: implications for efficacy of
adjuvant trastuzumab. Cancer Res. 73:1635–1646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bang YJ, Van Cutsem E, Feyereislova A,
Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T,
et al: Trastuzumab in combination with chemotherapy versus
chemotherapy alone for treatment of HER2-positive advanced gastric
or gastro-oesophageal junction cancer (ToGA): a phase 3,
open-label, randomised controlled trial. Lancet. 376:687–697. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iseri OD, Kars MD, Arpaci F, Atalay C, Pak
I and Gunduz U: Drug resistant MCF-7 cells exhibit
epithelial-mesenchymal transition gene expression pattern. Biomed
Pharmacother. 65:40–45. 2011. View Article : Google Scholar
|
|
25
|
McConkey DJ, Choi W, Marquis L, Martin F,
Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al: Role
of epithelial-to-mesenchymal transition (EMT) in drug sensitivity
and metastasis in bladder cancer. Cancer Metastasis Rev.
28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shah AN, Summy JM, Zhang J, Park SI,
Parikh NU and Gallick GE: Development and characterization of
gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol.
14:3629–3637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Z, Li Y, Kong D, Banerjee S, Ahmad A,
Azmi AS, Ali S, Abbruzzese JL, Gallick GE and Sarkar FH:
Acquisition of epithelial-mesenchymal transition phenotype of
gemcitabine-resistant pancreatic cancer cells is linked with
activation of the notch signaling pathway. Cancer Res.
69:2400–2407. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao Y, You H, Liu F, An H, Shi Y, Yu Q
and Fan D: Differentially expressed gene profiles between multidrug
resistant gastric adeno-carcinoma cells and their parental cells.
Cancer Lett. 185:211–218. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Szakacs G, Paterson JK, Ludwig JA,
Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in
cancer. Nat Rev Drug Discov. 5:219–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin K, He K, Han N, Li G, Wang H, Xu Z,
Jiang H, Zhang J and Teng L: Establishment of a PDTT xenograft
model of gastric carcinoma and its application in personalized
therapeutic regimen selection. Hepatogastroenterology.
58:1814–1822. 2011. View Article : Google Scholar : PubMed/NCBI
|
